Will BASI Hark Back To Its Heydays?

(RTTNews) - Shares of Bioanalytical Systems Inc. (BASI), which closed at a new 52-week high of $5.33, are up over 300 percent year-to-date.

Bioanalytical Systems is a pharmaceutical development company providing contract research services and monitoring instruments to pharmaceutical and agrochemical companies, biomedical research organizations and government-sponsored research centers.

The Company operates in two principal segments - Services and Products.

The Services segment provides research and development support on a contract basis directly to pharmaceutical companies and other clients, contributing a major chunk to the total revenue, while the Products segment provides liquid chromatography, electrochemical and physiological monitoring products to pharmaceutical companies, universities, government research centers, and medical research institutions. Currently, about 15% of its revenues are generated from customers outside of North America.

Bioanalytical Systems' fiscal year ends in September.
See also:
Leave a comment
  • Latest
  • Read
  • Commented
Calendar Content
«    Февраль 2020    »